Dong-A Socio Holdings Co., Ltd. (KRX:000640)
South Korea
· Delayed Price · Currency is KRW 98,100
-500 (-0.51%)
At close: Apr 18, 2025, 3:30 PM KST
Dong-A Socio Holdings Revenue
In the year 2024, Dong-A Socio Holdings had annual revenue of 1.33T KRW with 17.78% growth. Dong-A Socio Holdings had revenue of 346.93B in the quarter ending December 31, 2024, with 14.74% growth.
Revenue
1,333.23B
Revenue Growth
+17.78%
P/S Ratio
0.47
Revenue / Employee
241.09M
Employees
5,530
Market Cap
631.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,333.23B | 201.23B | 17.78% |
| Dec 31, 2023 | 1,132.00B | 117.14B | 11.54% |
| Dec 31, 2022 | 1,014.86B | 132.92B | 15.07% |
| Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
| Dec 31, 2020 | 783.32B | 13.63B | 1.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| LigaChem Biosciences | 125.90B |
| PharmaResearch | 350.12B |